Browsing by Author "Graveney, Mike"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Comparative Efficiency Analysis of Referral Costs inPublication . Portela, Maria; Thanassoulis, Emmanuel; Graveney, MikeThe aim of this paper is to compare English General Practitioner (GP) units in terms of their overall referral costs through Data Envelopment Analysis (DEA). Results revealed potential cost savings and benchmark practices under 4 perspectives: ‘overall cost efficiency’, ‘technical efficiency’, ‘allocative efficiency’, and ‘price efficiency’.
- Estimating the scope for savings in referrals and drug prescription costs in the general Practice units of a UK primary care trustPublication . Thanassoulis, Emmanuel; Portela, Maria C.A. Silva; Graveney, MikeThis paper explores the potential for cost savings in the general Practice units of a Primary Care Trust (PCT) in the UK. We have used Data Envelopment Analysis (DEA) to identify benchmark Practices, which offer the lowest aggregate referral and drugs costs controlling for the number, age, gender, and deprivation level of the patients registered with each Practice. For the remaining, non-benchmark Practices, estimates of the potential for savings on referral and drug costs were obtained. Such savings could be delivered through a combination of the following actions: (i) reducing the levels of referrals and prescriptions without affecting their mix (£15.74 m savings were identified, representing 6.4% of total expenditure); (ii) switching between inpatient and outpatient referrals and/or drug treatment to exploit differences in their unit costs (£10.61 m savings were identified, representing 4.3% of total expenditure); (iii) seeking a different profile of referral and drug unit costs (£11.81 m savings were identified, representing 4.8% of total expenditure).
- Using DEA to estimate potential savings at GP units at medicalPublication . Thanassoulis, Emmanuel; Portela, Maria Silva; Graveney, MikeChronic obstructive pulmonary disease (COPD) is characterised by a largely irreversible obstruction of the airways, and is one of the leading causes of chronic morbidity and mortality worldwide. This paper illustrates the use of Data Envelopment Analysis (DEA) to assess the potential for cost savings at COPD inpatient episode level. The analysis uses the length of stay of each episode as a surrogate for expenditure on that episode while allowing for the medical condition of the patient and the quality of care received. We find substantial possible reductions in length of stay which would translate to cost savings. The paper also explores differences both between hospitals and between care teams within hospitals so that cost efficient protocols of treatment can be identified and disseminated.